Sequential chemoimmunotherapy of colorectal cancer. Evaluation of methotrexate, Baker's antifol and levamisole (Q40964742)

reason for preferred rank

25 September 2017

title

Sequential chemoimmunotherapy of colorectal cancer. Evaluation of methotrexate, Baker's antifol and levamisole (English)

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

author name string

A. Y. Bedikian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

M. Valdivieso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

G. M. Mavligit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

M. A. Burgess

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

V. Rodriguez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

G. P. Bodey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A363254

8 April 2023

language of work or name

English

0 references

publication date

1 November 1978

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

1 reference

25 September 2017

volume

42

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

2169-2176

1 reference

A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary report

25 September 2017

cites work

1

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

5-fluorouracil given once weekly: Comparison of intravenous and oral administration

8 April 2023

2

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

8 April 2023

3

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

4

29

2308

Bruce

1969

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review

8 April 2023

5

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

7

60

769

Douglas

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Fluorouracil, methyl-CCNU and vincristine in cancer of the colon

8 April 2023

8

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

8 April 2023

9

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Nonparametric Estimation from Incomplete Observations

8 April 2023

12

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

15

60

1557

MacDonald

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma

8 April 2023

16

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine2

8 April 2023

18

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

19

32

1280

Moertel

1972

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Cancer Treatment Reports

20

60

729

Moertel

1976

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

21

37

980

Rodriguez

1977

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Levamisole in advanced human breast cancer

8 April 2023

22

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

23

29

2384

Schabel

1969

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

8 April 2023

24

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

8 April 2023

25

1 reference

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197811)42:5%3C2169::AID-CNCR2820420513%3E3.0.CO;2-V

8 April 2023

Identifiers

10.1002/1097-0142(197811)42:5<2169::AID-CNCR2820420513>3.0.CO;2-V

1 reference

25 September 2017

1 reference